Pearson Lab chairs an AI session at #ASCO24 and discusses two excellent abstracts that used prognostic and predictive multi-modal models in breast cancer and non-small cell lung cancer. UChicagoCancerCenter University of Chicago Hematology/Oncology

Fred Howard presents an excellent poster at #ASCO24 showing increased use of ChatGPT in generating scientific abstracts directed towards need to bring new policies. @Lab_Pearson UChicagoCancerCenter University of Chicago Hematology/Oncology

👀Simultaneous Publication Drop 🫳📜for #ASCO24 JCO Clinical Cancer Informatics. Full manuscript and detailed data now available . If you're curious how ASCO community is using #LLM #AI models to help write abstracts, check out our analysis Fred Howard Liz Garrett-Mayer, PhD 💻 👇 brnw.ch/21wKljc

Busy poster session for Fred Howard breaking down his research to #ASCO24 attendees interested in oncology #LLM applications.

Wonder where everyone is? We're all in S100a watching the head and neck cancer oral abstracts! #TuesdayAfternoonScience

Excellent presentation by Pearson Lab of pathway study #ASCO24 demonstrating improved PFS with pembrolizumab vs placebo in high risk #headandneckcancer particularly among salvage surgery and multiply recurrent subsets UChicagoCancerCenter

Huge congratulations to our rising stars, Fred Howard, MD (Fred Howard) and Anand Patel, MD (Anand Patel) on receiving #40Under40 in Cancer award.🎉🎉🎉 UChicagoCancerCenter University of Chicago Hematology/Oncology ow.ly/a42250SbUxO

OPTIMA II trial results published in JAMA Oncology demonstrating beneficial outcomes with neoadjuvant immunotherapy & chemotherapy in high risk HPV+ #OPC pts. Everett Vokes Ari Rosenberg Pearson Lab Aditya Juloori Nishant Agrawal UChicagoCancerCenter University of Chicago Hematology/Oncology ow.ly/1KXw50Sc2A1

Fred Howard and colleagues published a great study in JCO Clinical Cancer Informatics during #ASCO24 reporting increased use of AI tools in scientific writing, warning authors to be responsible for accurate representation of content. Pearson Lab University of Chicago Hematology/Oncology UChicagoCancerCenter ow.ly/hUTB50Sim17

Priviliged to have spent 4 days with friends and colleagues from all over the 🌎in the beautiful historic setting of AKSS Spetses for the first “Workshop on AI in Oncology: applications & challenges”. We interacted and learned from AI experts, delved into the exciting new world

Ugh. Program termination applies to: TrilynX (NCT04459715) XRAY VISION (NCT05386550)

Ecstatic to join 1st cohort of #CZBiohubCHI Investigators, with Esser-Kahn Lab + Peter Maurer. Our squad will use quantum-enabled IDs⚛️to eval individual immune cells in real-time to describe disease like malignant transformation🦀. Chan Zuckerberg Biohub Network UChicago Medicine The University of Chicago UChicagoCancerCenter

U.S. News & World Report's Best Hospitals list ranked University of Chicago Medical Center's Cancer and ENT programs highest in Illinois. Additionally, UCMC is one of only 25 hospitals nationwide to have at least 10 ranked specialties. uchicagomedicine.org/forefront/news…

Looking forward to this terrific session!

Check out our multi-center phase 2 IIT currently accruing for upfront SBRT added to Durvalumab-based chemoimmunotherapy for the first line treatment of extensive stage SCLC - the DARES trial. Christine Bestvina Docace911 clinical-lung-cancer.com/article/S1525-…

🚀 Big news! Slideflow 3.0 is here! 🎉 We've revamped our licensing (now Apache-2.0) to make Slideflow more open & accessible. We've added 3 foundation models (Virchow, UNI, GigaPath), upgraded MIL, & much more. Check it out: github.com/slideflow/slid… #AI #Pathology #OpenSource

Fantastic news!